Urszula Dougherty et al. revealed that VDR inhibits inflammation-to-cancer transition by negatively regulating the RAS and EGFR pathways, which increases Snail1 expression and reduces VDR expression in CRC cells [92]. This evidence concerns the gene VDR and colorectal carcinoma.